PA
AVXL icon

Profund Advisors’s Anavex Life Sciences AVXL Stock Holding History

Profund Advisors’s Portfolio AVXL Stock Details AVXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-64,223
Closed -$197K – 1187
2026
Q1 		$197K Buy
64,223
+6,251
+11% +$27.1K 0.01% 1036
2025
Q4 		$206K Buy
57,972
+34,072
+143% +$209K 0.01% 1145
2025
Q3 		$213K Buy
23,900
+4,047
+20% +$41K 0.01% 946
2025
Q2 		$183K Sell
19,853
-6,767
-25% -$57.8K 0.01% 923
2025
Q1 		$228K Buy
26,620
+11,240
+73% +$106K 0.01% 837
2024
Q4 		$165K Sell
15,380
-12,593
-45% -$96.9K 0.01% 1037
2024
Q3 		$159K Sell
27,973
-13,307
-32% -$76.8K 0.01% 1077
2024
Q2 		$174K Sell
41,280
-61,758
-60% -$250K 0.01% 1005
2024
Q1 		$524K Buy
103,038
+64,668
+169% +$364K 0.02% 561
2023
Q4 		$357K Sell
38,370
-7,595
-17% -$52.3K 0.02% 690
2023
Q3 		$301K Sell
45,965
-17,689
-28% -$141K 0.02% 663
2023
Q2 		$518K Sell
63,654
-22,258
-26% -$191K 0.03% 502
2023
Q1 		$736K Buy
+85,912
New +$857K 0.05% 386

Other funds holding AVXL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
SF
Summit Financial Parsippany, New Jersey $9.12B AUM 27.44% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Profund Advisors's AVXL Position: Q2 2026 in Review

Profund Advisors sold out of Anavex Life Sciences (AVXL) in Q2 2026, closing a stake of 64,223 shares — an estimated $197K sold.

Profund Advisors first reported a position in AVXL in Q1 2023 and held it in 13 quarters. The position peaked at $736K in Q1 2023. 179 funds tracked by Wall St. Rank hold AVXL as of Q2 2026.

  • Profund Advisors reported no remaining Anavex Life Sciences position as of Q2 2026 after selling out during the quarter.
  • Profund Advisors sold 64,223 Anavex Life Sciences shares in Q2 2026, an estimated $197K.
  • Profund Advisors first reported a position in Anavex Life Sciences in Q1 2023 and held it in 13 quarters.
  • Profund Advisors's Anavex Life Sciences position peaked at $736K in Q1 2023.
  • 179 funds tracked by Wall St. Rank held Anavex Life Sciences as of Q2 2026.

Based on Profund Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.